SCHEMBL7627264

SCHEMBL7627264

C#Cc1ccc(OCOC)c(C(=O)c2ccc(C)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
LMNA P02545 1/20 0.37
ABCB1 P08183 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36
AKR1C3 P42330 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EGFR P00533 2/20 0.35
CYP2C9 P11712 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
XDH P47989 1/20 0.35
MET P08581 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636181 0.87 MAPT (0.56) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL21483107 0.85 MAPT (0.50) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL30070841 0.85 MAPT (0.50) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL7632071 0.85 CTNNB1 (0.32) ALDH1A1CTNNB1WNT3AKDM4EEGFR
SCHEMBL8018090 0.84 CTNNB1 (0.33) MAPTALDH1A1CTNNB1WNT3ALMNA
SCHEMBL7632561 0.81 MAPT (0.42) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL31254287 0.81 HTT (0.46) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL8122356 0.79 ALDH1A1 (0.56) MAPTNPSR1HTTALDH1A1ABCB1
SCHEMBL8134825 0.78 TDP1 (0.50) MAPTNPSR1HTTALDH1A1POLB
SCHEMBL30785080 0.78 MAPT (0.46) MAPTNPSR1HTTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975573-B1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES INC (US) 2002-09-18 EP disclosed
US-6235923-B1 RETINOIDS AND CELL DIFFERENTIATION ALLERGAN SALES, INC. 2001-05-22 US disclosed
US-6225494-B1 TREATING SKIN DISORDERS, REDUCED SIDE EFFECTS ALLERGAN SALES, INC. 2001-05-01 US disclosed
US-6037488-A COMPOUNDS SUCH AS 4-((4'-ISOPROPOXY-3'-(1-M-TOLYL)VINYL)PHENYLETHYNYL)BENZOIC ACID ALLERGAN SALES, INC. (US) 2000-03-14 US disclosed
EP-0975573-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 2000-02-02 EP disclosed
WO-1998047854-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES, INC. (US) 1998-10-29 WO disclosed